Eam Investors, LLC Paratek Pharmaceuticals, Inc. Transaction History

Eam Investors, LLC

  • $581 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021
SELL
$6.14 - $8.31 $1.04 Million - $1.41 Million
-170,142 Closed
0 $0
Q4 2020

Feb 11, 2021
BUY
$4.58 - $7.14 $779,250 - $1.21 Million
170,142 New
170,142 $1.07 Million
Q4 2017

Feb 12, 2018
SELL
$17.45 - $25.6 $1.36 Million - $1.99 Million
-77,885 Closed
0 $0
Q3 2017

Nov 08, 2017
BUY
$18.9 - $28.2 $1.47 Million - $2.2 Million
77,885
77,885 $1.96 Million

Others Institutions Holding PRTK

# of Institutions
4
Shares Held
1.54M
Call Options Held
0
Put Options Held
0
View Full List

About Paratek Pharmaceuticals, Inc.

PRTK Quotes by TradingView
  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email